Books on the topic 'GlycoGag'

To see the other types of publications on this topic, follow the link: GlycoGag.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'GlycoGag.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

DiNuzzo, Mauro, and Arne Schousboe, eds. Brain Glycogen Metabolism. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-27480-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Savage, Madelyn. The Avian Glycogen body. Salford: University of Salford, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

R, Acharya K., ed. Glycogen phosphorylase b: Description of the protein structure. Singapore: World Scientific, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Martinez, Ana, Ana Castro, and Miguel Medina, eds. Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2006. http://dx.doi.org/10.1002/0470052171.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Patel, Mona D. Abnormalities in glycogen storage and metabolism in patients with liver-related diseases. Roehampton: University of Surrey Roehampton, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

library, Wiley online, ed. Glycogen synthase kinase 3 (GSK-3) and its inhibitors: Drug discovery and development. Hoboken, N.J: Wiley-Interscience, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Seal, Leonard Henry. Studies on glycogen in the nervous systems of Haemopis Sanguisuga and Planorbis Corneus. Salford: University of Salford, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Clement, Nichole S. The effects of the neurotoxin tetrodotoxin on glycogen content in rat soleus muscles. Sudbury, Ont: Laurentian University, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wender, Regina. Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. [Baltimore, MD]: Society for Neuroscience, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

1863-1902, Johnston Wyatt, ed. The medico-legal significance of the presence of sugar and glycogen in the liver post mortem. [S.l: s.n., 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Filosto, Massimiliano. Advances in diagnosis and management of glycogenosis II. Hauppauge, N.Y: Nova Science Publishers, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Müller, Rabea Annina. Phosphoinositide-3-kinases p110α and p110β mediate S phase entry in astroglial cells in the marginal zone of rat neocortex. Freiburg: Universität, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Crowley, John F. Chasing miracles: The Crowley family journey of strength, hope, and joy. New York: Newmarket Press, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

K, Welply Joseph, Jaworski Ernest, and University of California, Los Angeles., eds. Glycobiology: Proceedings of a Smith, Kline & French Laboratories-UCLA Symposium held at Frisco, Colorado, January 14-20, 1989. New York: Wiley-Liss, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Kurt, Drickamer, ed. Introduction to glycobiology. 3rd ed. Oxford: Oxford University Press, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Hunnisett, Douglas J. Leptin demonstrates no significant effect on basal or insulin-stimulated 2-deoxyglucose uptake and C14-labelled glucose incorporation into glycogen in L6 myotubes. Ottawa: National Library of Canada, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Anand, Geeta. The Cure. New York: HarperCollins, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Michèle, Aubery, ed. Glycans in cell interaction and recognition: Therapeutic aspects. Australia: Harwood Academic, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

1935-, Graucob E., ed. Hematologic cytology of storage diseases. Berlin: Springer-Verlag, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Carlin, James Irish. The effects of prolonged exercise and the ingestion of alanine and glucose during recovery on plasma carnitine and ketosis. Eugene: Microform Publications, College of Human Development and Performance, University of Oregon, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Acharya, K. R., D. I. Stuart, K. M. Varvill, and L. N. Johnson. Glycogen PhosphorylaseB. WORLD SCIENTIFIC, 1991. http://dx.doi.org/10.1142/1319.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Cassiman, David, Pascal Laforêt, and Fanny Mochel. Glycogen Storage Disorders. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199972135.003.0001.

Full text
Abstract:
Glucose is the body’s major energy source, and carbohydrate serves as fuel—particularly during high-intensity exercise that requires rapid energy release. A deficiency of any of the enzymes involved in the catabolism of glycogen to glucose may cause symptoms, with hypoglycemia and exercise intolerance as the most common presentations. Glycogen storage disorders (GSD) affect muscle, liver, and brain. The most common GSDs affecting muscle are GSD II (Pompe disease) and GSD V (McArdle disease). GSDs affecting mainly the liver are GSD I, III, IV, VI, IX, XI. Most liver-GSDs present during infancy, with symptoms of hypoglycemia, impressive hepatomegaly, and retarded growth. Adult presentations have been reported for GSD Ia, III, IV, and IX.Adult polyglucosan body disease (APBD) is the main GSD affecting primarily the brain and mainly characterized by spastic paraplegia, axonal neuropathy and leukodystrophy. APBD is a subtype of GSD IV and is due to a deficiency of glycogen branching enzyme (GBE). Besides GSD IV, other GSDs have been reported to have CNS effects in some patients—notably GSD II and GSD III.
APA, Harvard, Vancouver, ISO, and other styles
23

Wang, Tammy, Jocelyn Wong, and Anita Honkanen. Glycogen Storage Diseases. Edited by Kirk Lalwani, Ira Todd Cohen, Ellen Y. Choi, and Vidya T. Raman. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190685157.003.0048.

Full text
Abstract:
Glycogen storage diseases result from deficiencies of various enzymes or proteins in the pathways of glycogen metabolism. The reduction in effective glucose storage and/or mobilization results in hypoglycemia and accumulation of glycogen in tissues. Diagnosis can occur at any age, from infancy to adulthood, depending on the pathway affected and the degree of enzyme deficiency. The clinical presentation varies, but the most commonly affected organ systems include the heart, liver, and skeletal muscles. In addition to the morbidity that can occur from dysfunction of these organs, important anesthetic implications include administration of glucose-containing fluids to avoid hypoglycemia, monitoring for acidosis, and caution with use of depolarizing muscle relaxants because of the potential risk of hyperkalemia and rhabdomyolysis. Inheritance is commonly autosomal recessive.
APA, Harvard, Vancouver, ISO, and other styles
24

Schousboe, Arne, and Mauro DiNuzzo. Brain Glycogen Metabolism. Springer International Publishing AG, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Schousboe, Arne, and Mauro DiNuzzo. Brain Glycogen Metabolism. Springer, 2019.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Brown, Angus. Glycogen and Energy Metabolism. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199794591.003.0036.

Full text
Abstract:
This is a digitally enhanced text. Readers can also see the coverage of this topic area in the second edition of Neuroglia. The second edition of Neuroglia was first published digitally in Oxford Scholarship Online and the bibliographic details provided, if cited, will direct people to that version of the text. Readers can also see the coverage of this topic area in the ...
APA, Harvard, Vancouver, ISO, and other styles
27

Whelan, W. J., and Margaret P. Cameron. Control of Glycogen Metabolism. Wiley & Sons, Incorporated, John, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

Whelan, W. J., and CIBA Foundation Symposium Staff. Control of Glycogen Metabolism. Wiley & Sons, Limited, John, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Yu, Guangli, Hongzhi Cao, Hironobu Hojo, Tongzhong Ju, and Chung-Yi Wu. Synthetic Glycomes. Royal Society of Chemistry, The, 2019.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Methods on Glycoconjugates: A Laboratory Manual. Routledge, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Glycogen supercompensation in female distance runners. 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

Stambolic, Vuk. Regulation of glycogen synthase kinase-3. 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

Effect of adrenalectomy on diurnal glycogen fluctuation in rats. 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Acharya, K. R., D. I. Stuart, K. M. Varvill, and L. N. Johnson, eds. Glycogen Phosphorylase b: Description of the Protein Structure. World Scientific Publishing Co. Pte. Ltd., 1991. http://dx.doi.org/10.1142/9789814360401.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Stuart, D. I., K. M. Varvill, L. N. Johnson, and K. R. Acharya. Glycogen Phosphorylase-B: Description of the Protein Structure. World Scientific Publishing Company, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

Stuart, D. I., and K. R. Acharya. Glycogen Phosphorylase B: Description of the Protein Structure. World Scientific Publishing Company, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

Luo, Juan. Disruption of glycogen synthase kinase-3[Beta] in mice. 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

Abelson, John N., Melvin I. Simon, Gerald W. Hart, and William J. Lennarz. Guide to Techniques in Glycobiology. Elsevier Science & Technology Books, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

(Editor), John N. Abelson, Melvin I. Simon (Editor), William J. Lennarz (Editor), and Gerald W. Hart (Editor), eds. Guide to Techniques in Glycobiology (Methods in Enzymology). Academic Press, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
40

Wang, Binghe, Ana Martinez, Ana Castro, and Miguel Medina. Glycogen Synthase Kinase 3 and Its Inhibitors: Drug Discovery and Development. Wiley & Sons, Incorporated, John, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
41

(Editor), Ana Martinez, Ana Castro (Editor), Miguel Medina (Editor), and Binghe Wang (Editor), eds. Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery and Development (Wiley Series in Drug Discovery and Development). Wiley-Interscience, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
42

Observations on the glycogen content of certain invertebrates and fishes. [Toronto]: University Library, pub. by the Librarian, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
43

Carbohydrate feedings and exercise performance: Influence of muscle glycogen availability. 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
44

Glycogen resynthesis following submaximal and supramaximal exhaustive exercise in man. 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
45

Weiss, Pedro L., and Brian D. Faulkner. Glycogen: Structure, Functions in the Body and Role in Disease. Nova Science Publishers, Incorporated, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
46

Possible mechanism for changes in glycogen metabolism in unloaded soleus muscle. [Washington, D.C: National Aeronautics and Space Administration, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
47

Leslie G. (Leslie Gifford) Kilborn and J. J. R. (John James Rickard) MacLeod. Observations on the Glycogen Content of Certain Invertebrates and Fishes [microform]. Creative Media Partners, LLC, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
48

Beattie, R. Mark, Anil Dhawan, and John W.L. Puntis. Carbohydrate intolerance. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780198569862.003.0018.

Full text
Abstract:
Carbohydrates in the diet 128Carbohydrate digestion 129Hypolactasia/lactose intolerance 130Congenital sucrase–isomaltase deficiency 130Glucose–galactose malabsorption 131Confirmation of diagnosis of carbohydrate malabsorption 131Carbohydrates make up at least half the energy intake in the diet. The principal carbohydrates are the storage polysaccharides (starch, glycogen and cellulose), the disaccharides lactose and sucrose, and the monosaccharides glucose and fructose....
APA, Harvard, Vancouver, ISO, and other styles
49

Wera, S. Purification and Characterisation of the Glycogen-Bound Protein Phosphatase from Rat Liver. Leuven University Press, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
50

van der Ploeg, Ans T., and Pascal Laforêt. Pompe Disease. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199972135.003.0055.

Full text
Abstract:
Pompe disease, also named acid maltase deficiency and glycogen storage disease type II (GSDII), is a rare autosomal recessive disorder caused by the deficiency of the glycogen-degrading lysosomal enzyme acid α‎-glucosidase. The clinical spectrum of this disease is broad, varying from a lethal infantile-onset generalized myopathy including cardiomyopathy, to late-onset slowly progressive muscle weakness mimicking limb-girdle muscular dystrophy. Respiratory insufficiency is a frequent complication and the main cause of death. The prognosis of Pompe disease has changed considerably with the use of enzyme replacement therapy using recombinant acid α‎-glucosidase (alglucosidase alfa), which has been widely available since 2006. Improvements in survival and major motor achievements can be observed in patients with infantile forms, and recent studies demonstrate improvement of walking distance and stabilization of pulmonary function in late-onset forms. A longer-term study of the safety and efficacy of ERT, based on data gathering across the complete spectrum of Pompe disease via national or international patient registries, is needed in order to formulate more precise guidelines for treatment.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography